Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists

STAA - STAAR Surgical Co Stock Price, Fair Value and News

$25.25-0.62 (-2.40%)
Market Closed
Max Portfolio Pct.
Check
Valuation
Check

Stock Quality:

GPSDBMFI
Max Portfolio Pct.
Check
Valuation
Check
GPSDBMFI

STAA Price Action

Last 7 days

-1.6%

Last 30 days

-4.9%

Last 90 days

45.6%

Trailing 12 Months

-10.8%

STAA Stock Price

STAA RSI Chart

FebMarAprMayJunJulAugSepOct102030405060708090100

STAA Valuation

Market Cap

1.3B

Price/Earnings (Trailing)

-13.45

Price/Sales (Trailing)

5.71

EV/EBITDA

-12.5

Price/Free Cashflow

-29.3

STAA Price/Sales (Trailing)

2023202420255101520

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

STAA Fundamentals

STAA Revenue

Revenue (TTM)

224.4M

Rev. Growth (Yr)

-55.23%

Rev. Growth (Qtr)

4.06%

201020122014201620182020202220240100M200M300M400M

STAA Earnings

Earnings (TTM)

-95.3M

Earnings Growth (Yr)

-327.84%

Earnings Growth (Qtr)

68.99%

20102012201420162018202020222024-100M-80M-60M-40M-20M020M40M

STAA Profitability

EBT Margin

-43.47%

Return on Equity

-28.31%

Return on Assets

-21.76%

Free Cashflow Yield

-3.41%

STAA Investor Care

Shares Dilution (1Y)

0.74%

Diluted EPS (TTM)

-1.93

Revenue Breakdown

As of: Jun 30, 2025
20122014201620182020202220245M10M15M20M25M30M
Other Countries
GeographyValuePercent
TotalValuePercent

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
20102012201420162018202020222024050M100M150M200M250M300M350M400M
Net sales
YearQ1Q2Q3Q4
2025279.1M224.4M00
2024326.2M332.9M341.2M313.9M
2023294.7M305.9M310.2M322.4M
2022242.9M261.7M279.3M284.4M
2021179.0M206.2M217.5M230.5M
2020152.8M148.3M156.3M163.5M
2019129.4M135.2M142.5M150.2M
201897.4M109.3M117.6M124.0M
201783.5M84.5M87.9M90.6M
201677.5M79.9M81.2M82.4M
201573.7M72.3M72.8M77.1M
201474.4M76.3M77.4M75.0M
201366.3M68.5M69.7M72.2M
201263.4M63.1M63.7M63.8M
201156.0M58.7M60.8M62.8M
2010052.4M53.7M55.0M
200900051.1M
Get all data in R, Python etc through our Historical Stock Data APIs

About STAAR Surgical Co

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness. It also offers preloaded silicone cataract intraocular lenses and injector systems for use in cataract surgery. In addition, the company sells injector parts, and other related instruments and devices. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.
 CEO
 WEBSITEstaar.com
 SECTORHealthcare
 INDUSTRYMedical Instruments & Supplies
 EMPLOYEES882

STAAR Surgical Co Frequently Asked Questions

What is the ticker symbol for STAAR Surgical Co? What does STAA stand for in stocks?

STAA is the stock ticker symbol of STAAR Surgical Co. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of STAAR Surgical Co (STAA)?

As of Fri Oct 31 2025, market cap of STAAR Surgical Co is 1.28 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of STAA stock?

You can check STAA's fair value in chart for subscribers.

Is STAAR Surgical Co a good stock to buy?

The fair value guage provides a quick view whether STAA is over valued or under valued. Whether STAAR Surgical Co is cheap or expensive depends on the assumptions which impact STAAR Surgical Co's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for STAA.

What is STAAR Surgical Co's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Oct 31 2025, STAA's PE ratio (Price to Earnings) is -13.45 and Price to Sales (PS) ratio is 5.71. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. STAA PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on STAAR Surgical Co's stock?

In the past 10 years, STAAR Surgical Co has provided 0.117 (multiply by 100 for percentage) rate of return.